Back

BAFF

Emailer |

Healthcare

×

New Review Article: BAFF and APRIL in IgA Nephropathy

Click to view the template
Total Sent

11011

Deliveries
10971

(99.64%)

Unsubscribe

0.15%

17


Clicks

4.40%

484 (4.40%)

Open Rate
25.95%

25.95%

2857

Bounces: 13( 0.12%)
Forwards: (0.00%)
CTOR: (17.00%) 0.15%
×

New Perspectives in IgA Nephropathy Treatment: BAFF and APRIL

Click to view the template
Total Sent

8114

Deliveries
8110

(99.95%)

Unsubscribe

0.01%

1


Clicks

3.52%

286 (3.52%)

Open Rate
22.81%

22.81%

1851

Bounces: 2( 0.02%)
Forwards: (0.00%)
CTOR: (15.00%) 0.18%
×

New Perspectives in IgA Nephropathy Treatment: BAFF and APRIL

Click to view the template
Total Sent

19125

Deliveries
19081

(99.77%)

Unsubscribe

0.09%

18


Clicks

4.03%

770 (4.03%)

Open Rate
24.62%

24.62%

4708

Bounces: 15( 0.08%)
Forwards: (0.00%)
CTOR: (16.00%) 0.08%
×

Almost all patients with IgA nephropathy are at risk of kidney failure within their lifetime

Click to view the template
Total Sent

11011

Deliveries
10962

(99.55%)

Unsubscribe

0.12%

13


Clicks

3.51%

387 (3.51%)

Open Rate
28.66%

28.66%

3156

Bounces: 21( 0.19%)
Forwards: (0.00%)
CTOR: (12.00%) 0.11%
×

IgA nephropathy leads to dialysis or transplant in most patients

Click to view the template
Total Sent

7856

Deliveries
7842

(99.82%)

Unsubscribe

0.05%

4


Clicks

2.13%

167 (2.13%)

Open Rate
19.83%

19.83%

1558

Bounces: 8( 0.10%)
Forwards: (0.00%)
CTOR: (11.00%) 0.14%